Business
The worst mistake Moderna investors can make right now
This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.
In late 2018, Moderna Inc (NASDAQ: MRNA) went public in the largest biotech initial public offering (IPO) in history. Its value barely moved until mid-February 2020, when COVID-19 cases in the U.S. started showing up in multiple states. Now that its coronavirus vaccine has received Emergency Use Authorization, some investors might think there is limited upside left in the stock. That thinking might lead shareholders of Moderna to do the worst thing they could do right now.
Warp speed and beyond
Working with the National Institute of Allergy and Infectious Diseases, the company delivered a vaccine just 42 days after the…
-
General16 hours agoSex work influencers call out lack of transparency as young girls targeted by viral social media content
-
Noosa News12 hours agoGaming policy on council’s agenda
-
Business14 hours agoRanking the best “Magnificent Seven” stocks to buy for 2026. Here’s my No. 5 pick.
-
Noosa News15 hours agoRiders in good hands | Noosa Today